Danaher Corp (DHR)
235.36
-1.00
(-0.42%)
USD |
NYSE |
Apr 19, 16:00
235.36
0.00 (0.00%)
After-Hours: 16:55
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 174.10B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -7.31% |
| Valuation | |
| PE Ratio | 36.83 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 7.325 |
| Price to Book Value | 3.255 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.27 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3441 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.61% |
Profile
| In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto. |
| URL | https://www.danaher.com |
| Investor Relations URL | https://investors.danaher.com/ |
| HQ State/Province | District of Columbia |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 23, 2024 |
| Last Earnings Release | Jan. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2024 |
Ratings
Profile
| In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto. |
| URL | https://www.danaher.com |
| Investor Relations URL | https://investors.danaher.com/ |
| HQ State/Province | District of Columbia |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 23, 2024 |
| Last Earnings Release | Jan. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2024 |